RESTART LIFE SCIENCES — Proxy Solicitation & Information Statement 2025

Jan 8, 2025

restart

LIFE SCIENCES

RESTART LIFE SCIENCES CORP.

NOTICE OF ANNUAL GENERAL MEETING

Notice is hereby given that the Annual General Meeting (the “Meeting”) of the shareholders of Restart Life Sciences Corp. (the “Company”) will be held virtually on Friday, February 7, 2025, at the hour of 10:00 a.m. (Pacific Standard Time) for the following purposes:

1. To receive the audited annual financial statements of the Company for its financial year ended December 31, 2023;
2. To fix the number of directors of the Company at three (3);
3. To elect the directors of the Company for the ensuing year;
4. To appoint Kreston GTA LLP, Chartered Professional Accountants, as the Company’s auditor for the ensuing financial year and to authorize the directors to set the auditor’s remuneration;
5. To consider and, if thought fit, pass an ordinary resolution to approve the Company’s Stock Option Plan; and
6. To consider and, if thought fit, pass an ordinary resolution to approve the Company’s Restricted Share Unit Plan.

The Company is conducting the Meeting virtually. Registered shareholders and validly appointed proxyholders may attend the Meeting via Zoom at:

https://us06web.zoom.us/j/88697412418?pwd=gbHXvMia4tGJBHW6DPDBDPlNmb8vwH.1

Meeting ID: 886 9741 2418

Passcode: 153105

A registered shareholder of the Company entitled to attend and vote at the Meeting and is entitled to appoint a proxyholder to attend and vote in his stead. If you are unable to attend the Meeting virtually, please read the notes accompanying the instrument of proxy enclosed and then complete and return the proxy within the time set out in the notes. As set out in the notes, the enclosed instrument of proxy is solicited by management, but you may amend it, if you so desire, by inserting in the space provided the name of the person you wish to represent you at the Meeting. Non-registered shareholders of the Company should carefully follow the instructions received from their intermediary in respect of voting shares of the Company that they beneficially own, as more fully described under “Advice to Beneficial Holders of Common Shares” in the Information Circular.

DATED at Vancouver, British Columbia, this 27th day of December, 2024.

BY ORDER OF THE BOARD

“Steve Loutskou”, President & CEO